This is not the most recent version of the article. View current version (2 OCT 2013)

Intervention Protocol

Anti-vascular endothelial growth factor for neovascular glaucoma

  1. Arathi Simha1,*,
  2. Andrew Braganza1,
  3. Lekha Abraham1,
  4. Prasanna Samuel2,
  5. Kristina Lindsley3

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 8 JUL 2009

DOI: 10.1002/14651858.CD007920


How to Cite

Simha A, Braganza A, Abraham L, Samuel P, Lindsley K. Anti-vascular endothelial growth factor for neovascular glaucoma (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007920. DOI: 10.1002/14651858.CD007920.

Author Information

  1. 1

    Christian Medical College and Hospital, Department of Ophthalmology, Vellore, India

  2. 2

    Christian Medical College, Department of Biostatistics, Vellore, Tamil Nadu, India

  3. 3

    Johns Hopkins Bloomberg School of Public Health, Epidemiology, Baltimore, Maryland, USA

*Arathi Simha, Department of Ophthalmology, Christian Medical College and Hospital, Vellore, 632001, India. arathisimha@rediffmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2009

SEARCH

This is not the most recent version of the article. View current version (02 OCT 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the effects of intraocular anti-VEGF agents to no anti-VEGF injection as an adjunct to existing modalities for the treatment of NVG. In the subgroup of patients with NVG due to CRVO, we will also compare the effects of intraocular anti-VEGF alone to no anti-VEGF injection.